Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
about
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
@en
type
label
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
@en
altLabel
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV
@en
prefLabel
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
@en
P2093
P2860
P1433
P1476
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV
@en
P2093
Christian Marsolais
Jean-Claude Mamputu
Josée Morin
Julian Falutz
Julian Weiss
Lindsay T Fourman
Meghan N Feldpausch
Natalia Czerwonka
Steven K Grinspoon
P2860
P304
P356
10.1097/QAD.0000000000001614
P407
P577
2017-10-01T00:00:00Z